Navigation Links
Bio-hybrid device acts as 'thermostat' to control systemic inflammation in sepsis
Date:5/14/2012

PITTSBURGH, May 14 - A small, external bioreactor holding human cells pumped out an anti-inflammatory protein to prevent organ damage and other complications in a rat with acute inflammation caused by bacterial products in a model of sepsis, according to a report from researchers at the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine. The findings were published today in the inaugural issue of Disruptive Science and Technology.

Inflammation is a necessary biological response that brings cells and proteins to the site of tissue injury to contend with foreign agents, such as bacteria and the products they produce, and to begin the healing process, explained senior author Yoram Vodovotz, Ph.D., professor, Department of Surgery, and director, Center for Inflammation and Regenerative Modeling at the McGowan Institute. But sometimes, the inflammatory response escalates to create damage on its own, triggering more inflammation in a self-sustaining and dangerous cycle.

"In sepsis, for example, the inflammatory response evolves almost too quickly, but the available treatment strategies aim to prevent inflammation entirely," he said. "A better approach would be to turn down the response when it's too strong, yet still have appropriate inflammation signaling to promote tissue repair."

During inflammation, the body makes a protein called tumor necrosis factor-alpha, or TNF-α. It also makes its counterpart, soluble TNF-α receptor, or sTNFR, which binds to and reduces the level of TNF-α. In some situations, such as sepsis, not enough sTNFR is made to limit the inflammatory response.

Dr. Vodovotz and his team loaded a small bioreactor with human liver cells engineered to make sTNFR continuously. Through an intravenous line, blood from an anesthetized rat experiencing acute but transient inflammation was pumped through the bioreactor, exposing it to the engineered cells.
'/>"/>

Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-578-9193
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related biology technology :

1. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
2. New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety & Ease of Use, in a Wide Range of Patients Including Patients With a Challenging Anatomy
3. First successful human results achieved: Implantable wireless microchip drug delivery device
4. Research at Rice University leads to nanotube-based device for communication, security, sensing
5. Powerful AAC Device With Intel® i7 Processor Enables Natural Communication for Stroke, ALS and Autism Patients
6. ResearchMoz: Logic Integrated Circuit (IC) Market to 2020 - Programmable Logic Devices (PLD) and Application Specific Standard Product (ASSP) Dominate with a 78% Market Share
7. New method for enhancing thermal conductivity could cool computer chips, lasers and other devices
8. Low-cost paper-based wireless sensor could help detect explosive devices
9. FDA Establishes New Product Codes for Interbody Devices With Integrated Fixation
10. Drexel expert: Efficiency metrics for energy storage devices need standardization
11. New magnetic-field-sensitive alloy could find use in novel micromechanical devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Longmeadow, MA (PRWEB) September 16, 2014 ... appointment of Brian Highley as CEO of CIRTEC. ... this exciting point for the Company.” noted Brian Highley. ... operational performance while sustaining strong organic growth over the ... CIRTEC’s growth by continuing to improve and expand the ...
(Date:9/16/2014)... N.C. , Sept. 16, 2014  The ... oldest entrepreneurial support organization in the country, today ... Innovators Report . It showed ... North Carolina startups in the ... drew more global investment from a variety of ...
(Date:9/16/2014)... 2014   Synthetic Biologics, Inc. (NYSE ... biologic and drug programs targeting specific pathogens that ... of the Company,s Investor Day in ... bowel syndrome (IBS) program, including its novel, oral ... In the keynote presentation, Mark Pimentel , ...
(Date:9/16/2014)... Pharma Packaging Solutions announced ... for their 89th year in business. Adding ... Packaging Solutions is preparing packaging operations changes ... new procedures. Establishing training and system validation ... Pharma Packaging Solutions will be ready to ...
Breaking Biology Technology:CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 3Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2
... Incorporated (Nasdaq: SPEX ), an innovator in ... and providers of technical and regulatory consulting services to ... its President, Dr. Robert Lodder, will be presenting at ... Dr. Lodder will deliver the Company,s corporate presentation ...
... IRVING, Texas, Jan. 5, 2011 Signal Genetics, the ... predictive genetic testing company focused on oncology, and Caris ... enabling precise and personalized healthcare through the highest quality ... announced a new agreement under which Caris Life Sciences ...
... Corporation (Nasdaq: VRNM ), a pioneer in ... today announced that James Levine, Executive Vice President and ... Jaffray Sixth Annual Clean Technology & Renewables Conference.  The ... on Wednesday, January 12, 2011 and will take place ...
Cached Biology Technology:Spherix to Present at Two Upcoming Prominent Finance Conferences 2Spherix to Present at Two Upcoming Prominent Finance Conferences 3Signal Genetics and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test 2Signal Genetics and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test 3Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference 2Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference 3
(Date:9/15/2014)... both plants and animals alike. , Understanding just how ... to the design of better drugs for diabetes patients ... vegetables farmers are able to grow. Stanford University researchers ... cell by piecing together proteins slightly wider than the ... determine the size, shape and orientation of one of ...
(Date:9/15/2014)... have found "the most famous wheat gene," a reproductive ... transfer valuable genes from other plants to ... develop wheat varieties with the disease- and pest-resistance traits ... that can reduce crop losses and pesticide use while ... Modified Organisms, or GMOs., "The real exciting part of ...
(Date:9/15/2014)... WASHINGTON A new strategic vision document, released ... Research Program, describes the long-term goals, objectives, and ... scope of work over the next five years ... its initial, short-term activities, to be funded in ... and science policy fellowships. , The $500 ...
Breaking Biology News(10 mins):X-rays unlock a protein's SWEET side 2X-rays unlock a protein's SWEET side 3WSU researchers find 'most famous wheat gene' 2NAS Gulf Research Program announces strategic vision, initial opportunities 2NAS Gulf Research Program announces strategic vision, initial opportunities 3NAS Gulf Research Program announces strategic vision, initial opportunities 4
... producing proteins that moonlight, having different roles at different ... killed. The moonlighting activity of one enzyme from the ... of broad-spectrum antibiotics, according to a paper published in ... "Glutamate racemase, or MurI, is an enzyme ...
... many recent reports documenting the therapeutic efficacy of short ... may actually be describing non-specific therapeutic effects related to ... according to a paper in the September 2008 issue ... , a peer-reviewed journal published by Mary Ann Liebert, ...
... NY, Sept. 2, 2008) People concerned about the ... families and communities will have a unique opportunity to ... about the causes, symptoms and progression of such illnesses ... learn about current and potential treatments. In an ...
Cached Biology News:Energy-saving bacteria resist antibiotics 2Previous claims of siRNA therapeutic effects called into question by report in human gene therapy 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 3
Applications: Western blotting ...
...
... efficiencies and the chemistry of light production ... benefit that they require simple triggering conditions ... This benefit has been exploited to great ... compounds can also be easily modified to ...
ssDNA from PCR DNA in less than 1 hour. No gels, columns, or slurries. Sequence from high quality ssDNA: clearer reads, longer runs....
Biology Products: